Restore the heart.

Protect the brain.​​​

Cerebrovascular Events During TAVR
Cerebrovascular events occur in nearly all transcatheter aortic valve replacements (i.e.TAVR). These are associated with cognitive decline, 2- to 4-fold risk of future stroke, more than 3-fold risk of mortality, and more than 2-fold risk of dementia. Clinical cerebrovascular event rates as high as 9.1% have been reported following TAVR.


Come and meet Protembis at EuroPCR 2018

Paris, 22-25 May 2018

Latest News

The ProtEmbo Cerebral Protection System

Facts To Know About ProtEmbo
•  Low-profile access via left radial artery (6Fr guiding sheath)
•  Simple, quick and reliable deployment
•  Complete coverage of all 3 aortic side branches
•  Deflection of microparticles as tiny as 60 microns
•  Suitable for a wide variety of aortic arch anatomies
•  Heparin coating for optimal biocompatibility
•  Best access route: no interference with TAVR catheter or accessories

Protembis Achieves ISO 13485:2016 Quality Management System Certification

>> Press Release

ProtEmbo Deflects Embolic Material Away from the Brain During TAVR
ProtEmbo is the best-in-class system providing a simple, quick, reliable solution to reduce the risk of cerebrovascular events during transcatheter aortic valve replacement (TAVR).

Jan 9, 2018

CAUTION: The ProtEmbo® Cerebral Protection System is approved for investigational use in Europe.    ​​

© 2018 Protembis GmbH, all rights reserved.

Imprint     Privacy